ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
76 hedge funds and large institutions have $115M invested in Zynerba Pharmaceuticals, Inc in 2019 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 22 increasing their positions, 7 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
15% more call options, than puts
Call options by funds: $12.1M | Put options by funds: $10.5M
Holders
76
Holding in Top 10
–
Calls
$12.1M
Puts
$10.5M
Top Buyers
| 1 | +$30.3M | |
| 2 | +$13.8M | |
| 3 | +$9.37M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$8.49M |
| 5 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$5.48M |
Top Sellers
| 1 | -$1.18M | |
| 2 | -$1.12M | |
| 3 | -$968K | |
| 4 |
PP
PDT Partners
New York
|
-$476K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$427K |